Absorption, distribution, excretion, and pharmacokinetics of C 14 -pyronaridine tetraphosphate in male and female sprague-dawley rats

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Park, Sang Hyun ^a   Pradeep, Kannampalli ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PYRAMAX; PYRONARIDINE TETRAPHOSPHATE C 14; RADIOISOTOPE; UNCLASSIFIED DRUG; CARBON; CARBON DIOXIDE; NAPHTHYRIDINE DERIVATIVE; PYRONARIDINE;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; BREATHING; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; FECES; FEMALE; MALARIA CONTROL; MALE; NONHUMAN; PLASMODIUM FALCIPARUM; RADIOACTIVITY; RAT; SINGLE DRUG DOSE; SMALL INTESTINE; SMALL INTESTINE ABSORPTION; URINE; ABSORPTION; ANIMAL; BLOOD; BREATH ANALYSIS; CHEMISTRY; SPRAGUE DAWLEY RAT; TIME; TISSUE DISTRIBUTION;

RATTUS;

ABSORPTION; ANIMALS; BREATH TESTS; CARBON DIOXIDE; CARBON RADIOISOTOPES; FEMALE; MALE; NAPHTHYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 77951692790     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/590707     Document Type: Article

References (27)

1. World Malaria Report. World Health Organization, 2008
2. White N. J., Antimalarial drug resistance Journal of Clinical Investigation 2004 113 8 1084 1092
3. WHO, Antimalarial drug combination therapy 2001 Geneva, Switzerland WHO
4. Shao B., A review of antimalarial drug pyronaridine Chinese Medical Journal 1990 103 5 428 434 (Pubitemid 20305261)
5. Blessborn D., Lindegardh N., Ericsson O., Hellgren U., Bergqvist Y., Determination of pyronaridine in whole blood by automated solid phase extraction and high-performance liquid chromatography Therapeutic Drug Monitoring 2003 25 3 264 270 (Pubitemid 36638168)
6. Chang C., Lin-Hua T., Jantanavivat C., Studies on a new antimalarial compound: pyronaridine Transactions of the Royal Society of Tropical Medicine and Hygiene 1992 86 1 7 10
7. Fu S., Xiao S-H., Pyronaridine: a new antimalarial drug Parasitology Today 1991 7 11 310 313 (Pubitemid 121007896)
8. Ringwald P., Bickii J., Basco L., Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa The Lancet 1996 347 8993 24 28 (Pubitemid 26012413)
9. Wu L.-J., Rabbege J. R., Nagasawa H., Jacobs G., Aikawa M., Morphological effects of pyronaridine on malarial parasites American Journal of Tropical Medicine and Hygiene 1988 38 1 30 36 (Pubitemid 18036108)
10. Looareesuwan S., Kyle D. E., Viravan C., Vanijanonta S., Wilairatana P., Wernsdorfer W. H., Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand American Journal of Tropical Medicine and Hygiene 1996 54 2 205 209 (Pubitemid 26084442)
11. Ringwald P., Bickii J., Basco L., Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa The Lancet 1996 347 8993 24 28
12. Chavalitshewinkoon P., Wilairat P., Gamage S., Denny W., Figgitt D., Ralph R., Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro Antimicrobial Agents and Chemotherapy 1993 37 3 403 406
13. Qi J., Wang S., Liu G., Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo Biochemical and Biophysical Research Communications 2004 319 4 1124 1131
14. Auparakkitanon S., Chapoomram S., Kuaha K., Chirachariyavej T., Wilairat P., Targeting of hematin by the antimalarial pyronaridine Antimicrobial Agents and Chemotherapy 2006 50 6 2197 2200
15. Park S. H., Pradeep K., Seung H. J., Synthesis of C-14-labelled pyronaridine tetraphosphate Journal of Labelled Compounds and Radiopharmaceuticals 2007 50 14 1248 1254
16. Wages S. A., Patchen L. C., Churchill F. C., Analysis of blood and urine samples from Macaca mulata for pyronaridine by high-performance liquid chromatography with electrochemical detection Journal of Chromatography 1990 527 1 115 126
17. Nwaka S., Riopel L., Ubben D., Craft J. C., Medicines for malaria venture new developments in antimalarials Travel Medicine and Infectious Disease 2004 2 3-4 161 170
18. Wu L. J., Ultrastructural study on the effect of pyronaridine on the erythrocytic stages of chloroquine-resistant strain of Plasmodium berghei Journal of Parasitology and Parasitic Diseases 1986 4 4 263 266
19. Lee J., Son J., Chung S.-J., Lee E.-S., Kim D.-H., In vitro and in vivo metabolism of pyronaridine characterized by low-energy collision-induced dissociation mass spectrometry with electrospray ionization Journal of Mass Spectrometry 2004 39 9 1036 1043
20. Piola P., Fleckenstein L., Pharmacokinetics, clinical and safety outcomes of pyronaridine/artesunate treatment of acute Plasmodium falciparum malaria in Uganda Proceedings of the 57th Annual Meeting of the American Society of Tropical Medicine and Hygiene December 2008 New Orleans, La, USA 252. abstract no. 855
21. Duffy P. E., Sibley C. H., Are we losing artemisinin combination therapy already? The Lancet 2005 366 9501 1908 1909
22. Krishna S., Bustamante L., Haynes R. K., Staines H. M., Artemisinins: their growing importance in medicine Trends in Pharmacological Sciences 2008 29 10 520 527
23. Jambou R., Legrand E., Niang M., Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6 The Lancet 2005 366 9501 1960 1963
24. Vijaykadga S., Rojanawatsirivej C., Cholpol S., Phoungmanee D., Nakavej A., Wongsrichanalai C., In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003 Tropical Medicine and International Health 2006 11 2 211 219
25. Noedl H., Se Y., Schaecher K., Smith B. L., Socheat D., Fukuda M. M., Evidence of artemisinin-resistant malaria in Western Cambodia The New England Journal of Medicine 2008 359 24 2619 2620
26. Tjitra E., Ruangweerayut R., Socheat D., Valecha N., Treatment of acute Plasmodium vivax malaria with Pyramax (Pyronaridine tetraphosphate/artesunate) in a conrolled phase III clinical trial Proceedings of the 57th Annual Meeting of the American Society of Tropical Medicine and Hygiene December 2008 New Orleans, La, USA 255. abstract no. 865
27. Duparc S., Borghini-Fuhrer I., Craft J. C., Safety of pyronaridine/artesunate in clinical trials in patiens with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an integrated analysis Proceedings of the 58th Annual Meeting of the American Society of Tropical Medicine and Hygiene November 2009 Washington, DC, USA 147. abstract no. 517